PATENT CLAIM ANALYSIS

Application Number: 16112447
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["514", "738000"]

Abstract:
The present invention provides compositions and methods of their use in treating muscular dystrophy and other disorders.

Claim (Index 4):
A method of treating or inhibiting the development of muscle weakness in a subject that is a carrier of a mutated FKRP gene or without defect in glycosylation of \u03b1-DG, comprising administering to the subject an effective amount of a ribulose, thereby treating or inhibiting the development of muscle weakness.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 96.0
- Lexical Diversity: 1.05882
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15842580', '15880283', '15687196', '11143885', '15044598']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7394032324976366
- 35 USC 102 Novelty (BERT): 0.6501719267643057
- Combined Prediction Score: 0.7304801019243036
- Mean Citation Score: 411.0622320000001
- Max Citation Score: 661.2899
- Similarity Product: 567.7402429233789

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test